Analyst Research: Novavax Inc (NVAX.O)

NVAX.O on Nasdaq

5.92USD
26 Dec 2014
Price Change (% chg)

$0.11 (+1.89%)
Prev Close
$5.81
Open
$5.85
Day's High
$5.97
Day's Low
$5.73
Volume
1,209,095
Avg. Vol
4,006,283
52-wk High
$6.95
52-wk Low
$3.34

Search Stocks
Reports per page
Select Report Title Date Provider Pgs Price
Thomson Reuters Stock Report - NOVAVAX, INC. (NVAX-O) 5 Dec 2014 Thomson Reuters Stock Report 11 25.00
Trading Report for (NVAX). A detailed report, including free correlated market analysis, and updates. 4 Dec 2014 Stock Traders Daily 6 20.00
Novavax, Inc. (NVAX) - Financial and Strategic SWOT Analysis Review 4 Dec 2014 GlobalData 55 125.00
NVAX: Due Diligence Review: Forensic Earnings and Valuation 4 Dec 2014 New Constructs, LLC 9 25.00
"The Economy Matters" Report for NVAX: the economy's impact on NVAX's price and risk, featuring the powerful Economic Climate Rating and the new MacroRisk "Stoplight" and Risk Correspondence Score 2 Dec 2014 MacroRisk Analytics/EconomicInvestor 8 25.00
ValuEngine Rating and Forecast Report for NVAX 30 Nov 2014 ValuEngine, Inc. 11 25.00
Novavax Inc 29 Nov 2014 S&P Capital IQ Quantitative Report 10 115.00
Value Graph: NOVAVAX -- NVAX 27 Nov 2014 Ford Investor Services, Inc. 1 12.00
TheStreet.com Ratings Stock Report For: NOVAVAX INC (NVAX) 22 Nov 2014 TheStreet.com Ratings 5 10.00
 
Name Age Since Current Position

James Young

61 2011 Independent Chairman of the Board

Stanley Erck

66 2011 President, Chief Executive Officer, Director

Barclay Phillips

51 2013 Chief Financial Officer, Senior Vice President, Treasurer

Gregory Glenn

60 2014 Senior Vice President - Research & Development

Sven Andreasson

62 2014 Senior Vice President - Corporate Development
Search Stocks